REGENEREX PHARMA, INC. Shares Outstanding

Quick Answer

REGENEREX PHARMA, INC. reported Shares Outstanding of 281.07 million shares for fiscal year 2025.

REGENEREX PHARMA, INC. Shares Outstanding — Annual History

Fiscal Year Shares Outstanding YoY Change
2025 281.07M +1.0%
2024 278.23M +0.4%
2023 277.11M +0.0%
2022 277.11M +118.0%
2021 127.11M +0.0%
2020 127.11M +0.0%
2019 127.11M +0.0%
2018 127.11M -18.6%
2017 156.06M -0.2%
2014 156.41M +3.5%
2013 151.12M +1.4%
2012 149.08M -12.8%
2011 171.02M +178049.0%
2010 96,000

Quarterly Shares Outstanding

Quarter Ending Shares Outstanding YoY QoQ
September 30, 2025 281.75M +1.2% +0.2%
June 30, 2025 281.18M +1.0% +0.0%
March 31, 2025 281.07M +1.0% +0.9%
December 31, 2024 278.47M +0.2% +0.0%
September 30, 2024 278.44M +0.2% +0.1%
June 30, 2024 278.26M +0.3% +0.0%
March 31, 2024 278.23M +0.4% +0.1%
December 31, 2023 277.95M +0.3% +0.0%
  • REGENEREX PHARMA, INC. showed an increase of +1.0% in Shares Outstanding compared to the prior fiscal year.
  • Over the 2010–2025 period, REGENEREX PHARMA, INC.’s shares outstanding has grown by 292682.2% (from 96.0 thousand shares to 281.07 million shares).
  • The most recent figure is from REGENEREX PHARMA, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on June 30, 2025.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment